Duobrii clinical trials

A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion in Pediatric Subjects with Moderate to Severe Plaque Psoriasis

This study is looking at a new lotion called Duobrii for children and teenagers with moderate to severe plaque psoriasis. Doctors want to see how much of the medicine gets into the body, if it's safe to use every day, and how it affects important body functions.